Expression and Clinical Significance of Decoy Receptor 3 in Acute-on-Chronic Liver Failure
Table 1
Comparison of clinical characteristics and biomarkers between ACLF and non-ACLF groups of patients.
ACLF (n=76)
Non-ACLF (n=41)
P value
Age (years)
47.49 ± 15.24
43.95 ± 14.90
0.230
Male (%)
60 (78.95%)
30 (73.17%)
0.481
TBIL (μmol/L)
311.99 ± 160.46
79.96 ± 98.28
<0.001
Albumin (g/L)
30.65 ± 4.73
37.47 ± 6.26
<0.001
ALT (U/L)
220(100.75--703.00)
58 (32.00--227.00)
<0.001
AST (U/L)
207 (115.00--449.75)
58(30.00--163.00)
<0.001
γ-GT (U/L)
117(78.25--210.50)
59(27.00--135.00)
0.001
WBC (×109/L)
6.31(4.61--8.68)
5.19 (3.77--6.41)
0.007
N%
69.80 ± 10.39
57.21 ± 11.43
<0.001
Platelet (×109/L)
104.50 (63.00--135.75)
140.5 (98.00--201.50)
0.002
CRP(mg/L)
18.54(9.80--18.54)
12.44 (6.33--25.85)
0.333
PCT(ng/mL)
0.76(0.40--1.44)
0.43 (0.21--0.78)
0.011
PT(s)
21.05(17.33-24.93)
13.05 (12.25-14.88)
<0.001
INR
1.82 (1.49-2.24)
1.12 (1.02-1.29)
<0.001
Serum creatinine(umol/L)
63.00 (50.25-70.00)
64.20 (51.63-79.35)
0.273
DcR3(ng/mL)
0.97 (0.17- 2.32)
0.21 (0.11-0.49)
<0.001
Etiologies
0.737
HBV-related
64(82.89%)
33(80.49%)
others
9(13.16%)
5(12.20%)
Alcoholic
3(3.95%)
3(7.32%)
Data in this table were obtained upon admission and expressed as the number of patients (percentage), mean ± standard deviation, or mean (interquartile range).
